期刊文献+

低分子肝素预防妇科肿瘤术后下肢深静脉血栓形成的研究 被引量:14

Study on Low Molecular Weight Heparin for Preventing the Deep Vein Thrombosis of Lower Ex- tremities after Gynecological Cancer Surgery
下载PDF
导出
摘要 【目的】探讨妇科肿瘤术后早期应用低分子肝素预防下肢深静脉血栓(DVT)的临床疗效。【方法】89例妇科肿瘤手术患者随机分威肝素治疗组47例与对照组42例,治疗组术后12h、24h、48h均皮下注射低分子肝素5000μ,对照组不采用预防性用药。两组均记录盆腔引流量及拔除引流管时间,检测并比较术前、术后d3、d7双下肢静脉血管和血流情况,术前和术后d1、d2、d5、d7血小板、凝血功能、D-二聚体(D-D)等指标。【结果】治疗组和对照组相比,术后盆腔引流量和拔管时间比较无显著性差异(P〉0.05),术前与术后血小板、凝血功能比较无显著性差异(P〉0.05);治疗组D-D术后d1达到高峰,对照组D-D在术后d3达到高峰,且高值持续时间大于治疗组。血管彩超结果:对照组术后d7有7例患者下肢静脉血栓形成;治疗组术后d7有2例下肢静脉微小血栓。两组病人均未发生肺栓塞。【结论】低分子肝素可降低妇科肿瘤术后下肢深静脉血栓发生率,且不会增加术后出血危险。 [Objective]To explore the clinical efficacy of low molecular weight heparin(LMWH) used in early period after gynecological cancer surgery for preventing deep vein thrombosis(DVT) of lower extremities. [Methods]Totally 89 patients undergoing gynecological cancer surgery were randomly divided into LMWH treatment group( n =47) and control group( n =42). The treatment group was injected subcutaneously with LMWH 5000/1 at 12h, 24h and 48h after operation. The control group was not given prophylactic medication. The volume of pelvic drainage and extubation time in two groups were recorded. The blood flow of both lower extremities at d3 and dr before and after operation, platelet, coagulation, D-dimer and other indicators at d1 , d3, d5 and d7 before and after operation were measured and compared. [Results]There was no significant difference in postoperative pelvic drainage volume and extubation time between treatment group and control group( P 〉0.05). There was no significant difference in platelet and coagulation between before and after operation( P 〉0. 05). D-dimer in treatment group at dl after operation reached the peak, and that in control group at d3 after operation reached the peak. The duration of high value of D-dimer in treatment group was longer than that in control group. Vascular color ultra sound showed that DVT of lower extremities at d7 after operation was found in 7 cases ia control group and small vein thrombosis of lower extremitiesat d7 after operation was found in treatment group. No pulmonary embolism occurred in patients of two groups. [Conclusion] LMWH can effectively reduce the incidence of DVP of lower extremities after gynecological cancer surgery, and will not increase the risk of postoperative bleeding.
作者 王湘全
出处 《医学临床研究》 CAS 2011年第7期1305-1307,共3页 Journal of Clinical Research
关键词 生殖器肿瘤 女(雌)性/外科学 肝素 低分子量 腿/ 血液供给 血栓性静脉炎/预防和控制 genital neoplasms,female/SUl heparin,low-molecular-weight leg/BSl thrombophlebitis/ PC
  • 相关文献

参考文献9

  • 1韩伟峰,黄新天.深静脉血栓形成的临床流行病学研究[J].心肺血管病杂志,2008,27(3):187-190. 被引量:28
  • 2Kilic D,Akin S,Findkcioglu A,et al.Low-molecular-weight heparin for treatment of submissive pulmonary embolism after poeumonectomy[J].Gen Thorac Cardiovasc Surg,2007,55(7):287-289.
  • 3吴在德,吴肇汉,主编.外科学[M].第7版.北京:人民卫生出版社,2009:57.
  • 4Tateo S,Mereu L,Salamano S,et al.Ovarian cencer and venous thromboembobic risk[J].Gynecol Oncol,2005,99(1):119-125.
  • 5崔峰.下肢深静脉血栓形成早期低分子肝素治疗的安全性评价[J].中国现代医药杂志,2007,9(12):68-70. 被引量:22
  • 6Sjalander A,Jansson JH,Bergquist D,et al.Efficacy and safety of anticoagulaut prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients:a meta-analysis[J].J Intern Med,2008,263(1):52-60.
  • 7陈晓云,吴新民.硬膜外阻滞对胸科手术患者血液流变学及凝血功能的影响[J].中华麻醉学杂志,2004,24(6):410-414. 被引量:47
  • 8Righini M,Perrier A,De Moerloose P,et al.D-Dimer for venous thromboembolism diagnosis:20 years later[J].J Thromb Haemost,2008,6(7):1059-1071.
  • 9Becker DM,Philbrich JT,Humphries JE.D-dimer testing and acute venous thromboembolism[J].Arch Intern Med,1996,156(9):939-946.

二级参考文献13

  • 1[1]McRae SJ.Eikelboom JW.Latest medical treatment strategies for venous thromboembolism.Expert Opin Pharmacother.2007;8(9):1221-33
  • 2[2]Ernst CB,Stanley Jc.Current therapy in vascular surgery.3rd ed.USA:Mosby-Year Book,Inc,1995,888:936
  • 3[4]Chong BH,Brishton TA,Baker RI,etc.Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis,J Thromb Thrombolysis.2005,19(3):173-81
  • 4[5]van Dongen CJ,MacGillavry MR,Prins MH.Once versus twice daily LMWH for the initial treatment of venous thromboembolism.Once versus twice daily LMWH for the initial treatment of venous thromboembolism.Cochrane Database Syst Rev.2005,20(3):CD003074
  • 5[6]Hyers TM.Heparin and other rapidly acting anticoagulants.Semin Vasc Surg,2005,18(3):130-3
  • 6Naesh O , Hindberg I, Friis J, et al. General versus regional anaesthesia and platelet aggregation in minor surgery. Eur J Anaesthesiol , 1994,11:169-173.
  • 7Odoom JA, Bovill JG, Hardeman MR, et al. Effects of epidural and spinsl anesthesia on blood rheology. Anesth Analg, 1992,74:835-840.
  • 8Tuman KJ, Robert J, et al. Effects of epidural anesthesia and analgesia on coagulation and outcome after major vascular surgery. Anesth Analg,1991,73:696-704.
  • 9Egli GA, Zollinger A, Seifert B, et al. Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation. Br J Anaesth, 1997,78:684-689.
  • 10Porter J, Crowe B, Cahill M, et al. The effects of ropivacaine hydrochloride on platelet function: an assessment using the platelet function analyzer(PFA-100). Anaesthesia,2001,56:15-18.

共引文献103

同被引文献87

  • 1黄冬方,戴红,初玉平,张建军.低分子肝素在恶性肿瘤患者中心静脉置管过程中的应用观察[J].山东医药,2009,49(51):98-99. 被引量:2
  • 2杨柏柳,张震宇,郭淑丽.妇科手术后预防下肢深静脉血栓形成对患者凝血功能的影响[J].现代妇产科进展,2007,16(4):278-280. 被引量:28
  • 3程昭霞,史玉林,汪桂兰,聂小毳.丹参注射液预防妇科手术后患者下肢深静脉血栓形成的临床研究[J].实用药物与临床,2007,10(3):160-162. 被引量:7
  • 4Bowles L,Cohen H. Inherited thrombophilias and antieoagulation in reg- nancy[J]. Best Pratt Res Clin Obstet Gynaeco,2003,17 (3):471-489.
  • 5Zotz RB,Gerhardt A, Scharf RE. Prediction,prevention,antreatment of venous thromboembolie disease in pregnancy[J]. Semin Thromb Hemost, 2003,29 (2) : 143-154.
  • 6Fagnani D, Franchi R, Ports C, et al. Thrombosis-related complications and mortality in cancer patients with central venous devices:all observational study on the effect of an- tithrombotie prophylaxis [J. Ann Oncol, 2007, 18 : 551- 555.
  • 7Akl E A, Kamath G, Yosuico V, et al. Thromboprophy- laxis for patients with cancer and central venous cathe- ters:a systematic review and a meta-analysis[J. Cancer, 2008,112 : 2483-2492.
  • 8Flether J J, Stet]er W, Wilson T J, et a]. The clinical significance of peripherally inserted central venous cathe- ter-related deep vein thrombosis [J]. Neurocritieal Care, 2011,15(3) : 134-137.
  • 9Young A M, Billingham I J, Begum G, et al. Warfarin thromboprophy-laxis in cancer patients with central ve- nous catheters (WARP) : an open-label randomised trial [J]. Lancet,2009,373:567-574.
  • 10Klitfod L, Broholm R, Baekgaard N. Deep venous thrombosis of theupper extremity [J]. IntAngiol, 2013, 32(5): 447-452.

引证文献14

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部